| A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension D Kylhammar, B Kjellström, C Hjalmarsson, K Jansson, M Nisell, ... European heart journal 39 (47), 4175-4181, 2018 | 513 | 2018 |
| Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension C Hjalmarsson, G Rådegran, D Kylhammar, B Rundqvist, J Multing, ... European Respiratory Journal 51 (5), 2018 | 104 | 2018 |
| The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension D Kylhammar, G Rådegran Acta Physiologica 219 (4), 728-756, 2017 | 86 | 2017 |
| Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension D Kylhammar, R Hesselstrand, S Nielsen, C Scheele, G Rådegran Scandinavian journal of rheumatology 47 (4), 319-324, 2018 | 44 | 2018 |
| Predicting mortality during long-term follow-up in pulmonary arterial hypertension D Kylhammar, C Hjalmarsson, R Hesselstrand, K Jansson, M Kavianipour, ... ERJ Open Research 7 (2), 2021 | 29 | 2021 |
| P2Y1 and P2Y12 receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig D Kylhammar, LT Bune, G Rådegran European journal of applied physiology 114, 1995-2006, 2014 | 28 | 2014 |
| Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension D Kylhammar, L Persson, R Hesselstrand, G Rådegran Scandinavian Cardiovascular Journal 48 (4), 223-233, 2014 | 27 | 2014 |
| Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival A Sandqvist, D Kylhammar, SE Bartfay, R Hesselstrand, C Hjalmarsson, ... Scandinavian Cardiovascular Journal 55 (1), 43-49, 2021 | 25 | 2021 |
| Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016 B Kjellström, M Nisell, D Kylhammar, SE Bartfay, B Ivarsson, G Rådegran, ... ERJ Open Research 5 (3), 2019 | 24 | 2019 |
| Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction A Sandqvist, J Schneede, D Kylhammar, D Henrohn, J Lundgren, ... Heart and vessels 33, 255-263, 2018 | 24 | 2018 |
| Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment C Hjalmarsson, B Kjellström, K Jansson, M Nisell, D Kylhammar, ... ERJ open research 7 (3), 2021 | 18 | 2021 |
| s GC stimulation totally reverses hypoxia‐induced pulmonary vasoconstriction alone and combined with dual endothelin‐receptor blockade in a porcine model J Lundgren, D Kylhammar, P Hedelin, G Rådegran Acta physiologica 206 (3), 178-194, 2012 | 18 | 2012 |
| Cyclooxygenase‐2 inhibition and thromboxane A2 receptor antagonism attenuate hypoxic pulmonary vasoconstriction in a porcine model D Kylhammar, G Rådegran Acta physiologica 205 (4), 507-519, 2012 | 15 | 2012 |
| Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model A Wiklund, D Kylhammar, G Rådegran Journal of Cardiovascular Pharmacology 59 (5), 441-449, 2012 | 15 | 2012 |
| The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study K Torén, L Schiöler, A Lindberg, A Andersson, AF Behndig, G Bergström, ... Clinical physiology and functional imaging 41 (2), 181-191, 2021 | 14 | 2021 |
| Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia‐induced pulmonary vasoconstriction in a porcine model P Hedelin, D Kylhammar, G Rådegran Acta Physiologica 204 (3), 419-434, 2012 | 11 | 2012 |
| Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study K Toren, L Schiöler, A Lindberg, A Andersson, AF Behndig, G Bergström, ... BMJ Open Respiratory Research 7 (1), e000600, 2020 | 5 | 2020 |
| Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study CJ Östgren, J Otten, K Festin, O Angerås, G Bergström, K Cederlund, ... Cardiovascular Diabetology 22 (1), 261, 2023 | 3 | 2023 |
| Consequences of Using Post-or Prebronchodilator Reference Values in Interpreting Spirometry A Malinovschi, X Zhou, A Andersson, H Backman, B Bake, A Blomberg, ... American Journal of Respiratory and Critical Care Medicine 208 (4), 461-471, 2023 | 3 | 2023 |
| Pulmonary arterial hypertension: assessing risk to improve prognosis B Kjellström, C Hjalmarsson, D Kylhammar, G Rådegran Expert Review of Cardiovascular Therapy 17 (1), 1-2, 2019 | 3 | 2019 |
Jan EngvallProfessor i klinisk fysiologi, Linköpings UniversitetVerified email at liu.se
